Silicon Valley Capital Partners Merck & Co., Inc. Transaction History
Silicon Valley Capital Partners
- $670 Million
- Q1 2024
A detailed history of Silicon Valley Capital Partners transactions in Merck & Co., Inc. stock. As of the latest transaction made, Silicon Valley Capital Partners holds 59,902 shares of MRK stock, worth $7.06 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
59,902
Previous 50,250
19.21%
Holding current value
$7.06 Million
Previous $5.48 Million
44.29%
% of portfolio
1.18%
Previous 0.92%
Shares
6 transactions
Others Institutions Holding MRK
# of Institutions
3,825Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$28.8 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$24.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.8 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.54 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.72 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $299B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...